PDE3B antibody
Principal name
PDE3B antibody
Alternative names for PDE3B antibody
Phosphodiesterase 3B, Phosphodiesterase-3B cGMP-inhibited, HcGIP1, CGIPDE1, CGI-PDE B, CGIP, CGIP1, cGMP-inhibited 3',5'-cyclic phosphodiesterase B, Cyclic GMP-inhibited phosphodiesterase B
Ncbi ID
NP_000913.2, NP_000913, 9606, NP_035185.2, NM_000922, NM_017229
Available reactivities
Available hosts
Available applications
Frozen Sections (C), Immunoprecipitation (IP), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Flow Cytometry (F)
Background of PDE3B antibody
Cyclic nucleotides are hydrolyzed and compartmentalized by a family of enzymes called phosphodieterases. In mammals at least 11 different families of PDEs can be discriminated (PDE1-PDE11) based on their kinetic properties and inhibition to various pharmacological agents. The members of the PDE3 families are known as cGMP inhibited PDEs. The PDE3 enzymes bind both cGMP and cAMP with different affinities (cAMP 4-10-fold than cGMP). The phosphodiesterase type-3 (PDE3) family is comprised of 2 genes (PDE3A and PDE3B). PDE3A is a 145 kDa protein and is expressed in various tissues (myocardium, vascular and non vascular smooth muscles, megakaryocytes and a subset of neurons (Snyder 1999; Maecci et al., 1992). PDE3B is 1112 amino acids long and has two splice variants which are expressed in adipocyte tissue, hepatocyte, kidney, spermatocytes and embryonic neuroepithelium (Reinhatdt et. al., 1995). Both PDE3A and PDE3B are therapeutic targets for the treatment of obesity as inhibition of PDE3 increase the lipolytic activity and alter the insulin secretion and its response. PDE3 inhibitors also promote thermogenic and cardiotonic effects in animals.
General readings
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)
Yamano, Y., et al. Int. J. Cancer 126(2):437-449(2010)
Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)
Hanson, M.S., et al. Am. J. Physiol. Heart Circ. Physiol. 295 (2), H786-H793 (2008)
Raymond, D.R., et al. Cell. Signal. 19(12):2507-2518(2007)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA319015 | PDE3B antibody |
||||||
| Rabbit polyclonal anti-PDE3B antibody | |||||||
 |
Rabbit | Purified | Hu, Ms, Rt | WB |
0.2 mg /
€355.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA320441 | PDE3B antibody |
||||||
| Rat Anti-Mouse PDE3B Purified (25 ug) | |||||||
 |
Rat | SMCP3B | Purified | Ms | WB |
25 µg /
€210.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP00654SU-N | PDE3B antibody |
||||||
 |
Rabbit | Serum | Hu, Ms, Rt | C, IP, WB |
0.1 ml /
€440.00
|
||
| OriGene Technologies GmbH | |||||||
| AP53235PU-N | PDE3B (Center) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | F, ICC/IF, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
 +2 additional images |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP319619 | PDE3B |
||||
| Recombinant protein of human phosphodiesterase 3B, cGMP-inhibited (PDE3B) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€788.00
|
|
| OriGene Technologies, Inc. | |||||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR209284L2V | Lenti ORF particles, Pde3b (GFP-tagged ORF) - Rat phosphodiesterase 3B, cGMP-inhibited (Pde3b), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€2,430.00
|
|
| OriGene Technologies, Inc. | ||
| RR209284L1V | Lenti ORF particles, Pde3b (Myc-DDK-tagged ORF) - Rat phosphodiesterase 3B, cGMP-inhibited (Pde3b), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,190.00
|
|
| OriGene Technologies, Inc. | ||